Study of over 865,000 abortion pill patients: 11% suffer ‘serious adverse events’
Catholic News Agency
By Tyler Arnold
A first-of-its-kind study that delves into public health insurance records found that more than 1 in 10 women who take the abortion pill mifepristone to complete a chemical abortion will suffer a serious health complication during the process.
The study of 865,727 patients between 2017 and 2023, which was published by the Ethics and Public Policy Center (EPPC) on April 28, discovered that 10.93% of women suffer at least one “serious adverse event” within 45 days of taking mifepristone for an abortion.
“This isn’t idle speculation; this is based on the largest data set that we know of,” Ryan T. Anderson, the president of EPPC and one of the study’s authors, told EWTN.